Considering its importance in key cellular processes, TP53 is found to be mutated in ~ 50% of human cancers, more than any other gene in human cancers2. In this regard, Li–Fraumeni syndrome is a familial disorder that is associated with a TP53 mutation which predisposes carriers to a broad spectrum of cancers3. Here, TP53 is linked to cancer.